Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Angela Gravetti"'
Autor:
Claudio Cerchione, Giovanni Martinelli, Marco Picardi, Novella Pugliese, Davide Nappi, Aniello Casoria, Angela Gravetti, Delia Cangini, Maria Benedetta Giannini, Sonia Ronconi, Giorgia Simonetti, Andrea Ghelli Luserna Di Rorà, Ugo De Giorgi, Mattia Altini, Sara Bravaccini, Ilaria Santoriello, Cristiano Minucci, Fabrizio Pane, Vincenzo Martinelli
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 2, p 395 (2020)
Bone marrow aspiration and biopsy (BMAB) is a painful procedure, and the routinely used local infiltration anesthesia (LIA) with lidocaine is unable to provide pain relief during the most uncomfortable phases. The primary endpoint of the present rand
Externí odkaz:
https://doaj.org/article/e75fbbe210e84c66972df819a4594f8e
Autor:
Alessandro Broccoli, Cinzia Pellegrini, Alice Di Rocco, Benedetta Puccini, Caterina Patti, Guido Gini, Donato Mannina, Monica Tani, Chiara Rusconi, Alessandra Romano, Anna Vanazzi, Barbara Botto, Carmelo Carlo-Stella, Stefan Hohaus, Pellegrino Musto, Patrizio Mazza, Stefano Molica, Paolo Corradini, Angelo Fama, Francesco Gaudio, Michele Merli, Angela Gravetti, Giuseppe Gritti, Annalisa Arcari, Patrizia Tosi, Anna Marina Liberati, Antonello Pinto, Vincenzo Pavone, Filippo Gherlinzoni, Virginia Naso, Stefano Volpetti, Livio Trentin, Maria Cecilia Goldaniga, Maurizio Bonfichi, Amalia De Renzo, Corrado Schiavotto, Michele Spina, Sergio Storti, Angelo Michele Carella, Vittorio Stefoni, Lisa Argnani, Pier Luigi Zinzani
Publikováno v:
Haematologica, Vol 102, Iss 11 (2017)
Between November 2012 and July 2014, in accordance with national law 648/96, brentuximab vedotin was available in Italy for patients with relapsed systemic anaplastic large cell lymphoma outside a clinical trial context. A large Italian observational
Externí odkaz:
https://doaj.org/article/a663cbb1e87b4e5a949b59a8ab0a0e7f
Autor:
Sara Bravaccini, Mattia Altini, Delia Cangini, Marco Picardi, Vincenzo Martinelli, Maria Benedetta Giannini, Giorgia Simonetti, Ilaria Santoriello, Cristiano Minucci, Davide Nappi, Andrea Ghelli Luserna di Rorà, Sonia Ronconi, Aniello Casoria, Claudio Cerchione, Giovanni Martinelli, Fabrizio Pane, Angela Gravetti, Ugo De Giorgi, Novella Pugliese
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 2
Journal of Clinical Medicine, Vol 9, Iss 2, p 395 (2020)
Volume 9
Issue 2
Journal of Clinical Medicine, Vol 9, Iss 2, p 395 (2020)
Bone marrow aspiration and biopsy (BMAB) is a painful procedure, and the routinely used local infiltration anesthesia (LIA) with lidocaine is unable to provide pain relief during the most uncomfortable phases. The primary endpoint of the present rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b85f87e780eac482209bb5650670f7e3
http://hdl.handle.net/11588/823879
http://hdl.handle.net/11588/823879
Autor:
Angelo Fama, Cinzia Pellegrini, Francesco Gaudio, Paolo Corradini, Monica Tani, Corrado Schiavotto, Donato Mannina, Stefano Volpetti, Amalia De Renzo, Stefano Molica, Alessandra Romano, Filippo Gherlinzoni, Alessandro Broccoli, Livio Trentin, Carmelo Carlo-Stella, Maurizio Bonfichi, Stefan Hohaus, Annalisa Arcari, Antonello Pinto, Patrizia Tosi, Pier Luigi Zinzani, Angelo Michele Carella, Guido Gini, Pellegrino Musto, Patrizio Mazza, Alice Di Rocco, Anna Marina Liberati, Anna Vanazzi, Caterina Patti, Benedetta Puccini, Giuseppe Gritti, Chiara Rusconi, Michele Merli, Vincenzo Pavone, Sergio Storti, Michele Spina, Angela Gravetti, Maria Goldaniga, Barbara Botto, Virginia Naso, Lisa Argnani, Vittorio Stefoni
Publikováno v:
Haematologica
Between November 2012 and July 2014, in accordance with national law 648/96, brentuximab vedotin was available in Italy for patients with relapsed systemic anaplastic large cell lymphoma outside a clinical trial context. A large Italian observational
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::061446c439e66716b026ce7b7fd7da8b
http://hdl.handle.net/11577/3250024
http://hdl.handle.net/11577/3250024
Autor:
Vincenzo Martinelli, Giovanni Martinelli, Claudio Cerchione, Davide Nappi, Angela Gravetti, Roberta Della Pepa, Novella Pugliese, Lucio Catalano, Fabrizio Pane
Publikováno v:
Journal of Clinical Oncology. 37:e18313-e18313
e18313 Background: Bone marrow aspiration and biopsy (BMAB) is a painful procedure, and the commonly adopted local infiltration anesthesia (LIA) with lidocaine is unable to relieve the pain during the most uncomfortable phases, or the anticipatory an
Autor:
Filippo Gherlinzoni, Pier Luigi Zinzani, Angelo Michele Carella, Patrizia Tosi, Gian Matteo Rigolin, Stefano Molica, Anna Vanazzi, Caterina Patti, Alessandra Romano, Luigi Rigacci, Monica Tani, Patrizio Mazza, Giuseppe Gritti, Stefano Volpetti, Paolo Corradini, Virginia Naso, Maurizio Bonfichi, Stefan Hohaus, Lisa Argnani, Amalia De Renzo, Barbara Botto, Cinzia Pellegrini, Andrea Visentin, Angela Gravetti, Chiara Rusconi, Francesco Gaudio, Angelo Fama, Sergio Storti, Pellegrino Musto, Michele Merli, Antonello Pinto, Carmelo Carlo-Stella, Maria Goldaniga, Guido Gini, Michele Spina, Corrado Schiavotto, Donato Mannina, Annalisa Arcari, Anna Marina Liberati, Vincenzo Pavone
From November 2012 to July 2014, brentuximab vedotin (BV) was available in Italy for patients with relapsed systemic anaplastic large cell lymphoma (ALCL) outside a clinical trial context based on a local disposition of the Italian Drug Agency (AIFA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3efa8b24e1ada8570d3737450397971c
http://hdl.handle.net/11392/2364252
http://hdl.handle.net/11392/2364252
Autor:
Fioravante Ronconi, Carolina Copia, Salvatore Palmieri, Angela Gravetti, Felicetto Ferrara, Stefano Rocco, Giuseppe Monaco
Publikováno v:
Blood. 126:5300-5300
Introduction: The combination of fludarabine, cyclophoshamide and rituximab (FCR) represents the current standard of treatment of fit patients with chronic lymphocytic leukemia (CLL). However, despite the success of the FCR regimen, a number of quest
Autor:
Felicetto Ferrara, Angela Gravetti, Salvatore Palmieri, Cira Riccardi, Antonella Carbone, Giuseppe Monaco, Stefano Rocco, Carolina Copia, Fioravante Ronconi
Publikováno v:
Blood. 126:5380-5380
BACKGROUND. In recent years, new classes of drugs have been introduced for the treatment of Multiple myeloma (MM). Several randomized trials have investigated, in the setting of first line treatment of patients eligible for autologous transplant (ASC